Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05545540 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Music as an Adjunctive Epileptic Seizure Treatment Option

Study acronym: MAESTRO
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Jan 2, 2024 to Mar 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 1 to 2
    • Study completion date: Feb 2, 2024 to Dec 2, 2026
    v6
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v5
  3. Notable Start date: Jan 1, 2023 to Jun 1, 2023
    • Study title shortened, about 10 words
    v4
  4. Minor Re-verified, no change to tracked fieldsv3
  5. Minor Secondary endpoints: 1 to 6v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mozart's Sonata for two pianos in D major (K448) has been found to reduce the presence of abnormalities in the electroencephalograms of patients with epilepsy. We will examine the long term effects of listening to the K448 sonata on seizure frequency and cognitive functioning in children with drug resistant epilepsy allocated to either a study group or a control group. Patients' parents will complete a seizure diary for the whole study period, during which antiepileptic drug therapy of the child will remain unchanged. Baseline neuropsychological testing will be performed and a seizure diary will be kept for 3 months. The study group will listen to K448 for 8 continuous minutes every day for 2 months, while those in the control group will listen to control music for the same amount of time. Neuropsychological testing will be repeated at the end of the study period and any change from baseline examined. Seizure frequency during periods of exposure to music will be compared to baseline in both groups. Feedback questionnaires and parent focus groups will be used to gather information around the practicalities of exposure to music, potential problems and suggestions for how future studies might be improved.
Trial Details
NCT Number NCT05545540
Lead Sponsor University of Aberdeen
Collaborators: NHS Grampian
Conditions
(from sponsor)
Epilepsy, Neurocognitive Disorders
Related terms Epilepsy, Neurocognitive Disorders
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov